Archives of Clinical Neuropsychology,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 26, 2024
This
study
aims
to
adapt
and
provide
psychometric
support
for
the
validation
of
version
B
Edinburgh
Cognitive
Behavioural
ALS
Screen
(ECAS)
Portuguese
population,
addressing
need
consistent
cognitive
evaluations
in
amyotrophic
lateral
sclerosis
(ALS).
A
second
culturally
adapted
ECAS
screen
facilitates
accurate
characterization
progression,
mitigates
learning
effects,
supports
tailored
care
management.
Cellular and Molecular Life Sciences,
Год журнала:
2024,
Номер
81(1)
Опубликована: Март 2, 2024
Abstract
Amyotrophic
lateral
sclerosis
(ALS)
is
a
fatal,
severely
debilitating
and
rapidly
progressing
disorder
affecting
motor
neurons
in
the
brain,
brainstem,
spinal
cord.
Unfortunately,
there
are
few
effective
treatments,
thus
remains
critical
need
to
find
novel
interventions
that
can
mitigate
against
its
effects.
Whilst
aetiology
of
ALS
unclear,
ageing
major
risk
factor.
Ageing
slowly
progressive
process
marked
by
functional
decline
an
organism
over
lifespan.
However,
it
unclear
how
promotes
ALS.
At
molecular
cellular
level
specific
hallmarks
characteristic
normal
ageing.
These
highly
inter-related
overlap
significantly
with
each
other.
Moreover,
whilst
process,
striking
similarities
at
between
these
factors
neurodegeneration
Nine
were
originally
proposed:
genomic
instability,
loss
telomeres,
senescence,
epigenetic
modifications,
dysregulated
nutrient
sensing,
proteostasis,
mitochondrial
dysfunction,
stem
cell
exhaustion,
altered
inter-cellular
communication.
recently
(2023)
expanded
include
dysregulation
autophagy,
inflammation
dysbiosis.
Hence,
given
latest
updates
hallmarks,
their
close
association
disease
processes
ALS,
new
examination
relationship
pathophysiology
warranted.
In
this
review,
we
describe
possible
mechanisms
which
impacts
on
neurodegenerative
implicated
therapeutic
may
arise
from
this.
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(6)
Опубликована: Июнь 1, 2024
Amyotrophic
lateral
sclerosis
(ALS)
causes
motor
neuron
loss
and
progressive
paralysis.
While
traditionally
viewed
as
disease
(MND),
ALS
also
affects
non-motor
regions,
such
the
hypothalamus.
This
study
aimed
to
quantify
hypothalamic
subregion
volumes
in
patients
with
versus
healthy
controls
(HCs)
examine
their
associations
demographic
clinical
features.
Journal of Neurology,
Год журнала:
2024,
Номер
271(7), С. 3953 - 3977
Опубликована: Май 28, 2024
Amyotrophic
lateral
sclerosis
(ALS)
is
a
fatal
neurodegenerative
disease
characterized
by
the
progressive
degeneration
of
both
upper
and
lower
motor
neurons.
A
defining
histopathological
feature
in
approximately
97%
all
ALS
cases
accumulation
phosphorylated
trans-activation
response
(TAR)
DNA-binding
protein
43
(pTDP-43)
aggregates
cytoplasm
neurons
glial
cells
within
central
nervous
system.
Traditionally,
it
was
believed
that
TDP-43
subsequent
neurodegeneration
primarily
occurs
However,
contemporary
evidence
suggests
as
progresses,
other
systems
brain
regions
are
also
affected.
Despite
this,
there
has
been
limited
number
clinical
studies
assessing
non-motor
symptoms
patients.
These
often
employ
various
outcome
measures,
resulting
wide
range
reported
frequencies
The
importance
reflects
fact
they
have
significant
impact
on
patients'
quality
life,
yet
frequently
go
underdiagnosed
unreported
during
evaluations.
This
review
aims
to
provide
an
up-to-date
overview
current
knowledge
concerning
ALS.
Furthermore,
we
address
their
diagnosis
treatment
everyday
practice.
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(2), С. 545 - 545
Опубликована: Янв. 16, 2025
Introduction:
Amyotrophic
lateral
sclerosis
(ALS)
is
a
complex,
progressive
neurodegenerative
disorder
characterized
by
the
degeneration
of
motor
neurons
in
brain,
brainstem,
and
spinal
cord.
Several
neuroimaging
techniques
can
help
reveal
pathophysiology
ALS.
One
these
electroencephalogram
(EEG),
noninvasive
relatively
inexpensive
tool
for
examining
electrical
activity
brain
with
excellent
temporal
precision.
Methods:
This
mechanistic
review
examines
pattern
resting-state
EEG
activity.
With
focus
on
publications
published
between
January
1995
October
2024,
we
carried
out
comprehensive
search
2024
across
number
databases,
including
PubMed/Medline,
Research
Gate,
Google
Scholar,
Cochrane.
Results:
The
literature
yielded
17
studies
included
this
review.
varied
significantly
their
methodology
patient
characteristics.
Despite
this,
common
biomarker
typical
ALS
was
found-reduced
alpha
power.
Regarding
other
oscillations,
findings
are
less
consistent
sometimes
contradictory.
As
review,
three
possible
explanations
provided.
main
most
important
one
increased
cortical
excitability.
In
addition,
due
to
limitations
studies,
recommendations
future
research
topic
outlined
enable
further
better
understanding
patterns
Conclusions:
Most
showed
power
deficits
patients,
reflecting
pathological
hyperexcitability
cerebral
cortex.
Future
should
address
methodological
identified
small
sample
sizes,
inconsistent
frequency-band
definitions,
insufficient
functional
outcome
measures,
solidify
extend
current
findings.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,
Год журнала:
2024,
Номер
25(7-8), С. 726 - 736
Опубликована: Авг. 5, 2024
Introduction:
Amyotrophic
lateral
sclerosis
(ALS)
has
heterogeneous
manifestations
ranging
from
motor
neuron
degeneration
to
cognitive
and
behavioral
impairment.
This
study
aims
clarify
the
interactions
between
cognition
symptoms
with
relevant
disease
predictors
reserve
(CR),
quantified
through
education,
physical
activity,
occupation
proxies.
Methods:
A
prospective
sample
of
162
ALS
patients
61
controls
were
evaluated
Edinburgh
Cognitive
Behavioral
Screen
(ECAS)
(dependent
variable),
a
Reserve
Index
questionnaire
(CRIq)
demographic
data
(age
sex),
and,
for
patients,
clinical
variables:
duration,
site
onset,
Functional
Rating
Scale
(ALSFRS),
forced
vital
capacity
(FVC),
gene
mutation
chromosome
9
open
reading
frame
72
(C9orf72)
(independent
variables).
Multiple
regression
mediation
analyses
performed
predict
symptoms.
Results:
For
group,
statistical
model
explained
38.8%
variance
in
ECAS
total
(p
<
0.001),
59.4%
executive
functions
55%
0.001).
controls,
it
accounted
52.8%
Interaction
effects
analysis
showed
CR
is
an
modulator,
differential
effect
within
groups
Verbal
fluency
was
single
best
score
differentiate
=
0.004),
C9orf72
found
be
symptom'
predictor
0.009).
Conclusion:
supports
proposed
concept
that
acts
as
modulator
healthy
individuals.
Moreover,
also
modulates
ALS.
Cancers,
Год журнала:
2024,
Номер
16(15), С. 2680 - 2680
Опубликована: Июль 27, 2024
The
link
between
neurodegenerative
diseases
(NDs)
and
cancer
has
generated
greater
interest
in
biomedical
research,
with
decades
of
global
studies
investigating
biomarkers
to
better
understand
possible
connections.
Tau,
amyloid-β,
α-synuclein,
SOD1,
TDP-43,
other
proteins
associated
nervous
system
have
also
been
identified
various
types
solid
malignant
tumors,
suggesting
a
potential
overlap
pathological
processes.
In
this
review,
we
aim
provide
an
overview
current
evidence
on
the
role
these
cancer,
specifically
examining
their
effects
cell
proliferation,
apoptosis,
chemoresistance,
tumor
progression.
Additionally,
discuss
diagnostic
therapeutic
implications
interconnection,
emphasizing
importance
further
research
completely
comprehend
clinical
tumors.
Finally,
explore
challenges
opportunities
targeting
for
development
new
targeted
anticancer
therapies,
providing
insight
into
how
integrate
knowledge
NDs
oncology
research.
Neurological Sciences,
Год журнала:
2023,
Номер
45(5), С. 2075 - 2085
Опубликована: Дек. 18, 2023
Abstract
Background
Amyotrophic
lateral
sclerosis
(ALS)
can
present
with
either
bulbar
or
spinal
symptoms,
and
in
some
cases,
both
types
of
symptoms
may
be
present.
In
addition,
cognitive
impairment
has
been
observed
ALS.
The
study
aimed
to
evaluate
the
frontal
general
performance
ALS
not
only
cross-sectionally
but
also
longitudinally.
Methods
materials
Frontal
Assessment
Battery
(FAB)
Montreal
Cognitive
(MoCA)
were
employed
assess
function
52
adults
cognitively
healthy
individuals.
statistical
analyses
encompassed
Pearson
Chi
square
test,
Skillings-Mack
Spearman’s
rank
correlation
coefficient,
Proportional
Odds
Logistic
Regression
Model
(POLR).
Results
Cross-sectionally,
lower
was
associated
diagnosis,
older
age,
motor
functional
decline.
individuals
spinal-bulbar
showed
faster
deterioration
compared
those
symptoms.
subgroup
consistently
performed
worst
delayed
recall
attention,
while
subgroups
exhibited
inferior
scores
recall,
visuospatial
skills,
orientation,
verbal
fluency.
Conclusion
incorporation
screening
diagnostic
workup
beneficial,
as
early
detection
enhance
symptom
management
improve
quality
life
for
their
care
partners.
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(7)
Опубликована: Июль 1, 2024
Abstract
Background
Smell
loss
significantly
impacts
the
quality
of
life
in
patients.
However,
there
is
limited
research
on
smell
individuals
with
amyotrophic
lateral
sclerosis
(ALS),
and
correlation
between
cognitive
impairment
unclear.
This
study
aimed
to
investigate
cognition
ALS
Methods
The
included
216
Edinburgh
Cognitive
Behavioural
Screen
(ECAS)
identification
test
specifically
for
Chinese
population
(CSIT)
were
administered
evaluate
participants'
olfactory
function,
respectively.
Results
After
covarying
age,
sex,
BMI,
education
level,
degree
hunger,
dietary
bias,
eagerness
food,
stress,
smoking
status,
alcohol
consumption,
upper
respiratory
tract
infection
(URTI)
or
rhinitis,
CSIT
scores
correlated
ECAS
(
r
=
0.162,
p
0.028),
especially
ALS‐specific
0.158,
0.031).
Even
after
excluding
patients
URTI
results
similar.
0.224,
0.011),
0.205,
0.019).
Conclusion
In
ALS,
impairment,
particularly
frontotemporal
dysfunction.
dysfunction
may
lead
worse
performance
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,
Год журнала:
2024,
Номер
25(7-8), С. 717 - 725
Опубликована: Авг. 13, 2024
Recent
studies
suggest
that
psychological
resilience
(PR)
is
associated
with
more
well-preserved
cognition
in
healthy
subjects
(HS),
but
an
investigation
of
such
phenomenon
patients
motor
neuron
diseases
(MNDs)
still
lacking.
The
aim
our
study
was
therefore
to
evaluate
PR
and
its
relationship
baseline
cognitive/behavioral
mood
symptoms,
as
well
longitudinal
cognitive
functioning,
MNDs.